跳至主要内容
临床试验/DRKS00011722
DRKS00011722招募中不适用

Role of genetic polymorphisms in drug metabolizing cytochrome P450 enzymes expressed in the brain for affective disorders - BrainCYP

Bundesinstitut für Arzneimittel und Medizinprodukte0 个研究点目标入组 300 人开始时间: 2017年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • Written consent to the study
  • - Age restriction: 18-50 years
  • - Healthy to shlightly reduced general condition (ASA 1-2)
  • - BMI over 18 kg/m²
  • - Good german language skills
  • - Willingness and suitability for an MRI examination

排除标准

  • - In women: Pregancy or breastfeeding period
  • - Reduced general health condition
  • - Regular drug ingestion (with the exception of Thyroxin (Euthyreose), Statins, ACE-Inhibitiors or oral contraceptives)
  • - Metal implates (for example: pacemaker, copper spiral (in women), claustrophobia)
  • - other contraindications for nuclear resonance imaging
  • - consent incapable
  • - Indication for neurological or psychatric diseases
  • - No appropriate knowledge of german language to work on the questionnaires
  • - not-to-know incidental findings

研究者

相似试验

Role of genetic polymorphisms in drug metabolizing... | 临床试验